189 related articles for article (PubMed ID: 37842088)
1. Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors.
Feng H; Li H; Chen M; Zhang T; Zhou Y; Xu Y; Zhang W; Zhang T
Front Cell Dev Biol; 2023; 11():1289530. PubMed ID: 37842088
[No Abstract] [Full Text] [Related]
2. Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment.
Zhang R; Zhang Y; Qu X
Front Oncol; 2021; 11():827294. PubMed ID: 35071022
[No Abstract] [Full Text] [Related]
3. Exosomal circRNAs: Novel biomarkers and therapeutic targets for gastrointestinal tumors.
Wang D; Li R; Jiang J; Qian H; Xu W
Biomed Pharmacother; 2023 Jan; 157():114053. PubMed ID: 36462315
[TBL] [Abstract][Full Text] [Related]
4. Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy.
Li Z; Zhang X; Liu C; Ma J
Front Cell Dev Biol; 2021; 9():729941. PubMed ID: 34722510
[TBL] [Abstract][Full Text] [Related]
5. Editorial: New insights into antitumor mechanisms based on breast cancer immune microenvironment.
Yao Y; Wang T; Sun C
Front Genet; 2023; 14():1235699. PubMed ID: 37547467
[No Abstract] [Full Text] [Related]
6. Novel treatment targets in sarcoma: more than just the GIST.
Shoushtari AN; Van Tine BA; Schwartz GK
Am Soc Clin Oncol Educ Book; 2014; ():e488-95. PubMed ID: 24857144
[TBL] [Abstract][Full Text] [Related]
7. A gist of gastrointestinal stromal tumors: A review.
Rammohan A; Sathyanesan J; Rajendran K; Pitchaimuthu A; Perumal SK; Srinivasan U; Ramasamy R; Palaniappan R; Govindan M
World J Gastrointest Oncol; 2013 Jun; 5(6):102-12. PubMed ID: 23847717
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Traits in Cutaneous Melanoma.
Neagu M
Front Oncol; 2020; 10():851. PubMed ID: 32509589
[TBL] [Abstract][Full Text] [Related]
9. The Interaction of Genomics, Molecular Imaging, and Therapy in Gastrointestinal Tumors.
Wahl RL
Semin Nucl Med; 2020 Sep; 50(5):471-483. PubMed ID: 32768010
[TBL] [Abstract][Full Text] [Related]
10. Potassium channels, tumorigenesis and targeted drugs.
Xia C; Liu C; Ren S; Cai Y; Zhang Q; Xia C
Biomed Pharmacother; 2023 Jun; 162():114673. PubMed ID: 37031494
[TBL] [Abstract][Full Text] [Related]
11. Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review).
Zhang X; Meng T; Cui S; Liu D; Pang Q; Wang P
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616129
[TBL] [Abstract][Full Text] [Related]
12. Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.
Miller CL; Sagiv-Barfi I; Neuhöfer P; Czerwinski DK; Bertozzi CR; Cochran JR; Levy R
J Immunol; 2023 Jul; 211(2):295-305. PubMed ID: 37256255
[TBL] [Abstract][Full Text] [Related]
13. IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Karakasheva TA; Lin EW; Tang Q; Qiao E; Waldron TJ; Soni M; Klein-Szanto AJ; Sahu V; Basu D; Ohashi S; Baba K; Giaccone ZT; Walker SR; Frank DA; Wileyto EP; Long Q; Dunagin MC; Raj A; Diehl JA; Wong KK; Bass AJ; Rustgi AK
Cancer Res; 2018 Sep; 78(17):4957-4970. PubMed ID: 29976575
[TBL] [Abstract][Full Text] [Related]
14. p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.
Li X; Li F
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230657
[TBL] [Abstract][Full Text] [Related]
15. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
16. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors.
Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316
[TBL] [Abstract][Full Text] [Related]
17. Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor.
Wang J; Ren H; Wu W; Zeng Q; Chen J; Han J; Lin M; Zhang C; He Y; Li M
Front Immunol; 2021; 12():691713. PubMed ID: 34925310
[TBL] [Abstract][Full Text] [Related]
18. Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors.
Yan W; Zhang A; Powell MJ
Chin J Cancer; 2016 Jul; 35(1):68. PubMed ID: 27443349
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.
Wang X; Zhang Y; Mu X; Tu CR; Chung Y; Tsao SW; Chan GC; Leung WH; Lau YL; Liu Y; Tu W
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35105688
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated neutrophils: new targets for cancer therapy.
Gregory AD; Houghton AM
Cancer Res; 2011 Apr; 71(7):2411-6. PubMed ID: 21427354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
